Primary |
Atrial Fibrillation |
45.2% |
Hypertension |
17.8% |
Cerebrovascular Accident Prophylaxis |
5.3% |
Prophylaxis |
3.9% |
Thrombosis Prophylaxis |
3.0% |
Diabetes Mellitus |
2.8% |
Cardiac Failure |
2.7% |
Cardiac Failure Chronic |
2.5% |
Gastritis |
2.0% |
Insomnia |
2.0% |
Hyperlipidaemia |
1.9% |
Constipation |
1.7% |
Gastrooesophageal Reflux Disease |
1.7% |
Hyperuricaemia |
1.6% |
Arrhythmia |
1.4% |
Angina Pectoris |
0.9% |
Benign Prostatic Hyperplasia |
0.9% |
Chronic Obstructive Pulmonary Disease |
0.9% |
Cerebral Infarction |
0.8% |
Dementia |
0.8% |
|
Cerebral Infarction |
24.8% |
Embolic Stroke |
8.3% |
Renal Impairment |
6.9% |
Drug Ineffective |
6.2% |
Interstitial Lung Disease |
6.2% |
Wrong Technique In Drug Usage Process |
6.2% |
Shock Haemorrhagic |
5.5% |
Pulmonary Alveolar Haemorrhage |
4.8% |
Melaena |
3.4% |
Transient Ischaemic Attack |
3.4% |
Drug Effect Incomplete |
2.8% |
Lung Neoplasm Malignant |
2.8% |
Pneumonia |
2.8% |
Sepsis |
2.8% |
White Blood Cell Count Decreased |
2.8% |
Cardiac Failure Congestive |
2.1% |
Dizziness |
2.1% |
Eosinophilic Pneumonia |
2.1% |
Haemoptysis |
2.1% |
Haemorrhage |
2.1% |
|
Secondary |
Atrial Fibrillation |
39.6% |
Prophylaxis |
14.2% |
Hypertension |
9.0% |
Cerebrovascular Accident Prophylaxis |
8.0% |
Thrombosis Prophylaxis |
4.2% |
Cardiac Failure |
2.8% |
Chronic Atrial Fibrillation |
2.8% |
Embolic Stroke |
2.8% |
Blood Pressure Decreased |
1.9% |
Chronic Bronchitis |
1.9% |
Neurogenic Bladder |
1.9% |
Prophylaxis Against Gastrointestinal Ulcer |
1.9% |
Gastritis |
1.4% |
Hyperlipidaemia |
1.4% |
Hyperuricaemia |
1.4% |
Anaemia |
0.9% |
Benign Prostatic Hyperplasia |
0.9% |
Cerebral Infarction |
0.9% |
Cerebrovascular Accident |
0.9% |
Constipation |
0.9% |
|
Cerebral Infarction |
11.3% |
Renal Impairment |
7.5% |
Sepsis |
7.5% |
Haematuria |
5.7% |
Haemoptysis |
5.7% |
Interstitial Lung Disease |
5.7% |
Melaena |
5.7% |
Radioisotope Scan Abnormal |
5.7% |
Wrong Technique In Drug Usage Process |
5.7% |
Asphyxia |
3.8% |
Diabetes Mellitus |
3.8% |
Fall |
3.8% |
Heat Illness |
3.8% |
Hypoxia |
3.8% |
Liver Disorder |
3.8% |
Lung Neoplasm Malignant |
3.8% |
Mediastinal Abscess |
3.8% |
Neoplasm Prostate |
3.8% |
Non-alcoholic Steatohepatitis |
3.8% |
Aplasia Pure Red Cell |
1.9% |
|
Concomitant |
Product Used For Unknown Indication |
24.7% |
Rheumatoid Arthritis |
14.2% |
Atrial Fibrillation |
9.6% |
Prophylaxis |
8.2% |
Hypertension |
6.4% |
Cardiac Failure |
5.9% |
Constipation |
2.7% |
Cough |
2.7% |
Embolic Stroke |
2.7% |
Osteoporosis |
2.7% |
Prophylaxis Against Gastrointestinal Ulcer |
2.7% |
Thrombosis Prophylaxis |
2.7% |
Back Pain |
1.8% |
Benign Prostatic Hyperplasia |
1.8% |
Dementia Alzheimer's Type |
1.8% |
Diabetes Mellitus |
1.8% |
Dizziness |
1.8% |
Gastric Ulcer |
1.8% |
Gastritis |
1.8% |
Insomnia |
1.8% |
|
Cerebral Infarction |
7.7% |
Rash |
7.7% |
Restlessness |
7.7% |
Stomatitis |
7.7% |
Tuberculosis |
7.7% |
Tubulointerstitial Nephritis |
7.7% |
Atrial Fibrillation |
3.8% |
Cholecystitis Acute |
3.8% |
Death |
3.8% |
Drug-induced Liver Injury |
3.8% |
Haemoglobin Decreased |
3.8% |
Hepatitis Fulminant |
3.8% |
Hypokalaemia |
3.8% |
Lung Neoplasm Malignant |
3.8% |
Pneumonia |
3.8% |
Pneumonia Aspiration |
3.8% |
Prothrombin Time Prolonged |
3.8% |
Pyrexia |
3.8% |
Rash Generalised |
3.8% |
Renal Failure Acute |
3.8% |
|